Bortezomib in Treating Patients With Advanced or Metastatic Sarcoma

NCT00027716 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Sarcoma

Interventions

DRUG: bortezomib

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]